BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-34@pharmaconomics
DTSTAMP:20260707T021628Z
DTSTART;VALUE=DATE:20270425
DTEND;VALUE=DATE:20270426
SUMMARY:ORMP Phase 3 — ORMD-0801 8 mg
DESCRIPTION:Phase 3 trial results for ORMD-0801 8 mg in Type 2 Diabetes Mellitus are due Apr 25\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT06731075\n\nTrack it: https://pharmaconomics.com/e/34
URL:https://pharmaconomics.com/e/34
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ORMP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR